Some patients diagnosed with certain types of cancer may soon have the options to skip chemotherapy, radiation and surgery in favor of immunotherapy treatment, according to a new study published in ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Yeah, I think in terms of research ...

Todd Schlesinger, MD, discusses how new immunotherapies and multidisciplinary care are reshaping treatment approaches for patients with advanced skin cancers. This content was developed independently ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Healio spoke with Charu Aggarwal, MD, MPH, about ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, joins Chris Cuomo to discuss the future of cancer ...

Dr. Brittany Dulmage discusses how management of immune-related side effects can help patients stay on immunotherapy without compromising its effectiveness. As immunotherapy continues to transform ...

The phase 3 ATOMIC trial is changing the way we treat stage III dMMR colon cancer. In this video, Dr. Sinicrope breaks down ...

A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...

Add Yahoo as a preferred source to see more of our stories on Google. White House chief of staff Susie Wiles has breast cancer. She'll join the 'ranks' of women who keep working during treatment.

Immunotherapy and targeted therapy are often the first lines of treatment for advanced kidney cancer, with surgery and radiation also possible.

Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...